Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 74 for “"memantine"”.

  1. Demenzspezifische medikamentöse Behandlung mit Acetylcholinesterase-Hemmern und Memantine – Unter- und Fehlversorgung?

    … mit Acetylcholinesterase-Hemmern (AChEI) und Memantine bei hausärztlich betreuten Alzheimer- bzw. Demenzpatienten. Des Weiteren sollten Determinanten auf ihre Assoziation mit einer Einnahme/Verschreibung von Antidementiva identifiziert werden. Die vorliegende Untersuchung basiert auf Daten, …

    qucosa-diss

  2. The uncompetitive NMDA receptor antagonist memantine blocks compulsive eating of palatable food

    … NMDA receptor antagonists, ketamine and memantine, and found that memantine significantly decreased FR1 responding and compulsive eating of palatable food, but not chow, and reduced the difference in risk- taking behavior between the palatable-fed and chow-fed groups. Site-specific …

    bu Repository record for The uncompetitive NMDA receptor antagonist memantine blocks compulsive eating of palatable food (opens in a new tab)

  3. The Protective Effects of Memantine On The Morphology and Activity of Irradiated Dendritic Spines

    Abstract: The Protective Effects of Memantine on the Morphology And Activity of Irradiated Dendritic Spines Thanh T. Lam, M.S. Advisory Professor: David R. Grosshans, M.D, Ph.D. Although radiotherapy is an effective treatment for brain tumors, the adverse effects of such treatments may result in a …

    uthsc Repository record for The Protective Effects of Memantine On The Morphology and Activity of Irradiated Dendritic Spines (opens in a new tab)

  4. Interaction of memantine with ethanol consumption and dopaminergic function in high ethanol preferring rats

    … these drugs often produce adverse side effects. Memantine is a neuroprotective and low-affinity, noncompetitive NMDA receptor antagonist shown to be an effective treatment for Alzheimer's disease with a favorable clinical profile. This study investigated effects of memantine on volitional ethanol …

    ecu Repository record for Interaction of memantine with ethanol consumption and dopaminergic function in high ethanol preferring rats (opens in a new tab)

  5. Die Wirkung des NMDA-Rezeptorantagonisten Memantine auf die Wahrnehmung von noxischen und nicht-noxischen Temperaturreizen auf der Haut beim Menschen

    … ob der nichtkompetitive NMDA-Rezeptorantagonist Memantine die Wahrnehmung noxischer und nichtnoxischer Temperaturreize beim Menschen signifikant beeinflusst. Dazu wurden bei 40 Probanden, doppelblind und placebokontrolliert die Wahrnehmungsschwellen für Warm-, Kalt- und Hitzeschmerzreize …

    wurz-thes Repository record for Die Wirkung des NMDA-Rezeptorantagonisten Memantine auf die Wahrnehmung von noxischen und nicht-noxischen Temperaturreizen auf der Haut beim Menschen (opens in a new tab)

  6. Εκτίμηση ασφάλειας και αποτελεσματικότητας των φαρμάκων που χρησιμοποιούνται στην αντιμετώπιση της άνοιας: μετα-ανάλυση

    … whether Cholinesterase Inhibitors (ChEIs) and memantine are superior to placebo in the treatment a) of Alzheimer’s disease (AD) for at least 6 months b) of Vascular Dementia (VaD). Methods: Extensive literature search in three electronic databases (PubMed, Cochrane Database, EMBASE) and four …

    greece Repository record for Εκτίμηση ασφάλειας και αποτελεσματικότητας των φαρμάκων που χρησιμοποιούνται στην αντιμετώπιση της άνοιας: μετα-ανάλυση (opens in a new tab)

  7. Causal Inference Methods for Estimation of Survival and General Health Status Measures of Alzheimer’s Disease Patients

    … of Alzheimer’s disease drugs, Donepezil and Memantine, and their combined use on Survival and General Health Status Measures of Alzheimer's disease patients for the first five years after initial diagnosis. We carried out a thorough causal inference study using doubly robust estimators, …

    chapman Repository record for Causal Inference Methods for Estimation of Survival and General Health Status Measures of Alzheimer’s Disease Patients (opens in a new tab)

  8. Coupling extrasynaptic NMDA receptors to aberrant intracellular signaling in Huntington disease

    … (2-month) treatment of YAC128 and WT mice with memantine (1 and 10mg/kg/d), which at a low dose selectively blocks Ex-NDMARs, reduced striatal Ex-NMDAR expression in YAC128 mice without altering synaptic NMDAR levels. In contrast, calpain activity was not affected by memantine treatment, and was …

    ubc Repository record for Coupling extrasynaptic NMDA receptors to aberrant intracellular signaling in Huntington disease (opens in a new tab) Download PDF for Coupling extrasynaptic NMDA receptors to aberrant intracellular signaling in Huntington disease (opens in a new tab)

  9. Modulation of NMDA Receptor Activity During Physiological and Pathophysiological Events

    … could lead to more rational drug design. Memantine and ketamine are NMDAR open channel blockers that exhibit similar pharmacodynamics at NMDARs but have different clinical uses. Memantine improves cognitive decline during Alzheimer's disease. Ketamine is an anesthetic and analgesic with …

    wustl Repository record for Modulation of NMDA Receptor Activity During Physiological and Pathophysiological Events (opens in a new tab)

  10. Synaptic Mechanisms Underlying Treatment of Depression and Bipolar Disorder

    … effects without the potential side effects. Memantine is a NMDAR antagonist similar to ketamine in many regards but does not produce antidepressant effects in patients. Behavioral experiments in mice recapitulated clinical findings showing that ketamine but not memantine has …

    utswmed Repository record for Synaptic Mechanisms Underlying Treatment of Depression and Bipolar Disorder (opens in a new tab)

  11. Repurposing Alzheimer’s disease medications in a drug combination for the study of the crosstalk between cell apoptosis and autophagy in the modulation of cell death in chronic myeloid leukaemia

    … but low concentrations (1, 5 and 10 μM) of Memantine and Donepezil (AD drugs) were shown to be non-toxic in this study, as they induced no measurable cell death in both cell lines tested, with Memantine (1 μM) increasing the viability of HEK293T (the AD cell model) by 41% (p < 0.05). …

    middlesex Download PDF for Repurposing Alzheimer’s disease medications in a drug combination for the study of the crosstalk between cell apoptosis and autophagy in the modulation of cell death in chronic myeloid leukaemia (opens in a new tab)

  12. Behavioral effects of chronic morphine treatment: From tolerance to executive functions and interactions with N-methyl-D-aspartate receptor antagonists

    … adjuncts to opioids in chronic pain management. Memantine is a channel blocker that binds to dizocilpine binding sites. As a lower affinity NDMAR antagonist, memantine is well tolerated, and has positive cognitive effects. To help evaluate the potential use of memantine as an adjunct to opioids …

    ttu Repository record for Behavioral effects of chronic morphine treatment: From tolerance to executive functions and interactions with N-methyl-D-aspartate receptor antagonists (opens in a new tab)

  13. Assessment of novel therapeutic approaches in the YAC128 mouse model of Huntington disease

    … model of HD. We examined whether treatment with memantine, a clinically well-tolerated NMDA receptor antagonist, can improve the phenotype of YAC128 mice. We demonstrated that treatment with memantine results in improvements in motor function and rescues the striatal deficits in a dose-specific …

    ubc Repository record for Assessment of novel therapeutic approaches in the YAC128 mouse model of Huntington disease (opens in a new tab) Download PDF for Assessment of novel therapeutic approaches in the YAC128 mouse model of Huntington disease (opens in a new tab)

  14. EVALUATION OF GENE REGULATION AND THERAPEUTIC DRUGS RELATED TO ALZHEIMER’S DISEASE IN DEGENERATING PRIMARY CEREBROCORTICAL CULTURES

    … action of the NMDA receptor antagonist memantine. Treatment with memantine prevented loss of synaptic markers and preserved neuronal morphology, while having no apparent effect on glial activation. The protective action on synaptic markers was also observed with two other structurally …

    iupui Repository record for EVALUATION OF GENE REGULATION AND THERAPEUTIC DRUGS RELATED TO ALZHEIMER’S DISEASE IN DEGENERATING PRIMARY CEREBROCORTICAL CULTURES (opens in a new tab)

  15. Effects of (+) MK-801 (dizocilpine) and non-coding RNA on aggregation of beta-amyloid peptides linked to Alzheimer's Disease

    … reported here, the effects of (+) MK-801 and of memantine on the aggregation pathway of Abeta(1-40) and Abeta(1-42) peptides have been examined using the Thioflavin T fluorescence assay, nuclear magnetic resonance spectroscopy, and electron microscopy. Memantine is FDA-approved for the treatment …

    cornell Repository record for Effects of (+) MK-801 (dizocilpine) and non-coding RNA on aggregation of beta-amyloid peptides linked to Alzheimer's Disease (opens in a new tab)

  16. Strategies of neuroprotection in an in vivo model of retinal degeneration induced by mitochondrial dysfunction

    … This work also tested the effects of memantine, an NMDA receptor blocker, to further characterize the relationship between excitotoxicity and mitochondrial dysfunction. Neuroprotective effects were evaluated via behavioral testing of visual function and histopathological analysis of …

    texas Repository record for Strategies of neuroprotection in an in vivo model of retinal degeneration induced by mitochondrial dysfunction (opens in a new tab)

  17. Therapy of stroke with novel neuroprotective and anti-inflammatory agents

    … Ca2 + channels. NGPl-01 was compared to memantine (20 mg/kg i.p), a clinically approved neuroprotective drug, acting as an open channel blocker at NMDA receptors. Third, we quantified the receptor-mediated binding and uptake of antitransferrin receptor monoclonal antibody, 8D3, under …

    ttu Repository record for Therapy of stroke with novel neuroprotective and anti-inflammatory agents (opens in a new tab)

  18. Living with Lewy body dementia. Treatment, survival & quality of life.

    … comprise of LBD patients included in an RCT of memantine (Study I-II) and from the Memory Clinic, Malmö, Sweden (Study III-V).Results: I) Physical activity during sleep decreased in LBD patients treated with memantine compared to placebo over 24 weeks. II) Quality of life in LBD is constructed …

    lund Repository record for Living with Lewy body dementia. Treatment, survival & quality of life. (opens in a new tab) Download PDF for Living with Lewy body dementia. Treatment, survival & quality of life. (opens in a new tab)

  19. A cost-benefit analysis of Alzheimer’s disease treatment options

    … donepezil, rivastigmine, galantamine, memantine, and memantine-donepezil combination. Aducanumab is the only disease-modifying drug to receive FDA approval, but its efficacy is marred in controversy and it lacks cost-effectiveness. The remaining five drugs all have similar …

    bu Repository record for A cost-benefit analysis of Alzheimer’s disease treatment options (opens in a new tab)

Page 1 of 4